Product Image

Ginkgo Biloba Certified Extract 120 mg

Life Extension
4.7
★ ★ ★ ★ ★
(4599 ratings)
Ginkgo
Product Image
Score84
A high-quality full-serving ginkgo extract with strong purity disclosure. It is one of the more dependable options for focused cognitive-circulation support.
How scoring works
Quantity:365 Capsule(s) • (365 servings)
Goals:
Cognitive Support
Brain Health
Mental Focus
Productivity Boost
Vision Support

Score 84

A high-quality full-serving ginkgo extract with strong purity disclosure. It is one of the more dependable options for focused cognitive-circulation support.
How scoring works
$39.75($0.10 per serving)
iHerb
$ 39.75
Vitacost
$ 39.75
Pure Formulas
$ 39.75
Amazon
$ 39.75
iHerb
$ 39.75
Report prices

Analysis

The capsule supplies a full 120 mg of certified ginkgo extract and identifies both flavone glycosides and total terpene lactones. A very low ginkgolic-acid limit adds meaningful purity reassurance that many competing labels lack.

Ginkgo may support cerebral circulation, memory, and processing speed, particularly for sustained use or age-related needs. Its role in vision remains limited to circulation and does not replace macular carotenoids or retinal fats.

The one-capsule format and large supply suit long-term users who want a well-specified extract. It remains a single-pathway formula, so broader cognitive or eye goals may require complementary nutrients.

Who is it for
  • Adults seeking a purified ginkgo extract
  • People focused on memory and processing support
  • Long-term single-capsule users
Best for
  • Sustained cognitive routines
  • Cerebral-circulation support
  • Users who prioritize purity data

Pros

  • Provides a full daily extract amount
  • Names both major marker classes
  • States a strict ginkgolic-acid limit

Cons

  • Marker percentages are not shown
  • Single ingredient limits pathway breadth
  • Vision support remains indirect

Warnings

  • Ginkgo may increase bleeding risk with anticoagulants or antiplatelet medicines.
  • Bleeding risk around surgery should be reviewed with the surgical team.
  • Headache, dizziness, or digestive discomfort may occur.

Nutrient quality

90 Highest impact

Named active-marker groups and a very low ginkgolic-acid limit provide strong purity assurance. The formula supplies a full target-range extract amount, with no obvious overdosing.

.

Ingredient transparency

81 Highest impact

The main active amounts are clearly listed, and no proprietary blend hides them. Intake directions, non-active ingredients, and some extract-quality details are absent from the supplied data.

.

Customer satisfaction

69 High impact

The supplied average is strong and the response volume is substantial. No detailed feedback is provided to assess recurring complaints or fit with the intended purpose.

.

Value for money

95 Highest impact

Verified quality and serving efficiency support strong practical value. The formula compares favorably with many category alternatives.

.
Report analysis

Goals

Cognitive Support
Impact
Highest effect
B+ Goal FitA+ Strength of SupportC- CoverageA Formula Quality

Certified ginkgo extract directly targets cerebral circulation and may support memory and processing speed. The clinical-range amount names both marker groups and includes a strict ginkgolic-acid purity limit.

Support remains focused on circulation rather than neurotransmitters or stress-related cognition. Ginkgo may increase bleeding risk with anticoagulants or antiplatelet medicines.

Study evidence
Ginkgo Supportive 87 studies
Brain Health
Impact
Highest effect
B+ Goal FitA Strength of SupportC CoverageA- Formula Quality

The 120 mg ginkgo extract targets cerebral circulation and cognitive performance with both flavone glycosides and terpene lactones identified. A very low ginkgolic-acid limit adds strong purity reassurance.

Marker percentages are not shown, leaving some uncertainty about exact standardization. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 90 studies
Mental Focus
Impact
Highest effect
B Goal FitA Strength of SupportC CoverageB+ Formula Quality

A full amount of ginkgo extract may support attention and processing through cerebral circulation. Both key marker groups and a strict ginkgolic-acid limit are identified, though their percentages are not shown.

The formula is narrow and better suited to sustained cognitive support than an immediate alertness boost. Ginkgo can increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 28 studies
Productivity Boost
Impact
High effect
B- Goal FitA- Strength of SupportC- CoverageA+ Formula Quality

A full serving of a purified ginkgo extract may support mental clarity and attention through cerebral circulation. Evidence is more consistent for memory concerns than for immediate productivity in healthy adults.

The focused formula identifies the main ginkgo marker groups and sets a very low ginkgolic-acid limit, although marker percentages are missing. Ginkgo can increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Vision Support
Impact
High effect
D+ Goal FitB+ Strength of SupportD CoverageA- Formula Quality

Ginkgo may support ocular microcirculation, making it situationally relevant when blood flow to the optic nerve or retina is a concern. The 120 mg certified leaf extract is supplied at a commonly used amount.

Evidence for broad vision protection is limited compared with macular carotenoids or established antioxidant combinations. Ginkgo can increase bleeding risk with anticoagulant or antiplatelet medicines and may also raise bleeding risk around surgery.

Study evidence
Ginkgo Supportive 11 studies

Ingredients

IngredientAmount per serving
Ginkgo biloba (leaf) extract (<1 ppm Ginkgolic Acid, Ginkgo Flavone Glycosides, Total Terpene Lactones)
120 mg
Adults 18–50
Report overview
B- Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyA+ Value

The extract delivers a full target daily amount and clearly identifies both major active-marker groups. A very low ginkgolic-acid limit provides strong purity assurance, although the marker percentages are not stated in the supplied data. The unusually low cost per serving makes it an efficient choice for a dedicated ginkgo product.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledBrain Health Cognitive Support forGinkgo
  2. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
    van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P · Journal of clinical epidemiology · 2003
    Randomized trial214 participantsBrain Health forGinkgo
  3. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  4. Comparative effects of Bacopa monnieri and Ginkgo biloba on cognitive functions: A systematic review and network meta-analysis.
    Tiemtad P; Ingkaninan K; Temkitthawon P; Thimkorn P; Rattanachaisit N; Teaktong T; Dhippayom T · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2026
    Meta-analysis2,107 participants29 studies pooledMental Focus forGinkgo
  5. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  6. Electrophysiological analysis of the effects of ginkgo biloba on visual processing in older healthy adults.
    Page JW; Findley J; Crognale MA · The journals of gerontology. Series A, Biological sciences and medical sciences · 2006
    Clinical trialVision Support forGinkgo
  7. Ginkgo biloba--an appraisal.
    Dubey AK; Shankar PR; Upadhyaya D; Deshpande VY · Kathmandu University medical journal (KUMJ) · 2007
    Narrative reviewVision Support forGinkgo
  8. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsVision Support forGinkgo
  9. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  10. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  11. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledBrain Health Productivity Boost forGinkgo
  12. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  13. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  14. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  15. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  16. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  17. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  18. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  19. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  20. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  21. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  22. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  23. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  24. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  25. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  26. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo
  27. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsVision Support forGinkgo
  28. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsVision Support forGinkgo
  29. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsVision Support forGinkgo